Greatest opportunities for growth in nuclear cardiology

Greatest opportunities for growth in nuclear cardiology EDITOR’S PAGE Greatest opportunities for growth in nuclear cardiology Vasken Dilsizian, MD, MASNC Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD Received May 17, 2017; accepted May 17, 2017 doi:10.1007/s12350-017-0933-9 The indispensable factor of sustaining any field of deposition have important clinical, therapeutic, and 99m science or intellectual endeavor is the influx of new prognostic implications. Tc-pyrophosphate imaging ideas and solutions to previously unsolved, but in prin- provides the opportunity to diagnose cardiac amyloido- ciple solvable problems. Over the last four decades, sis, evaluate cardiac amyloid load quantitatively, myocardial perfusion imaging has been the dominant differentiate light-chain amyloidosis from transthyretin- procedure in nuclear cardiology. A number of clinical related cardiac amyloidosis, monitor disease progres- trials have demonstrated the diagnostic and prognostic sion, and assess response to treatment. accuracy of gated myocardial perfusion studies with Targeting specific biological or chemical pathways SPECT or PET, and its relevance for patient manage- to assess normal and abnormal cellular function in vivo 1–3 ment. However, it has become increasingly apparent is the basis of molecular imaging. For example, that in the hands of the specialists, nuclear cardiology molecular imaging allows direct visualization and has grown progressively http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Nuclear Cardiology Springer Journals

Greatest opportunities for growth in nuclear cardiology

Loading next page...
 
/lp/springer_journal/greatest-opportunities-for-growth-in-nuclear-cardiology-p49z20F6W9
Publisher
Springer Journals
Copyright
Copyright © 2017 by American Society of Nuclear Cardiology
Subject
Medicine & Public Health; Cardiology; Nuclear Medicine; Imaging / Radiology
ISSN
1071-3581
eISSN
1532-6551
D.O.I.
10.1007/s12350-017-0933-9
Publisher site
See Article on Publisher Site

Abstract

EDITOR’S PAGE Greatest opportunities for growth in nuclear cardiology Vasken Dilsizian, MD, MASNC Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD Received May 17, 2017; accepted May 17, 2017 doi:10.1007/s12350-017-0933-9 The indispensable factor of sustaining any field of deposition have important clinical, therapeutic, and 99m science or intellectual endeavor is the influx of new prognostic implications. Tc-pyrophosphate imaging ideas and solutions to previously unsolved, but in prin- provides the opportunity to diagnose cardiac amyloido- ciple solvable problems. Over the last four decades, sis, evaluate cardiac amyloid load quantitatively, myocardial perfusion imaging has been the dominant differentiate light-chain amyloidosis from transthyretin- procedure in nuclear cardiology. A number of clinical related cardiac amyloidosis, monitor disease progres- trials have demonstrated the diagnostic and prognostic sion, and assess response to treatment. accuracy of gated myocardial perfusion studies with Targeting specific biological or chemical pathways SPECT or PET, and its relevance for patient manage- to assess normal and abnormal cellular function in vivo 1–3 ment. However, it has become increasingly apparent is the basis of molecular imaging. For example, that in the hands of the specialists, nuclear cardiology molecular imaging allows direct visualization and has grown progressively

Journal

Journal of Nuclear CardiologySpringer Journals

Published: May 30, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off